 |
 |
 |
|
|
|
 |
NEWS |
 |
|
|
|
|
 |
Transgene creates a subsidiary in China and signs Immunocan
 |
|
| Transgene, a publicly traded French biopharmaceutical company dedicated to the development of therapeutic vaccines and immunotherapeutic products in oncology and infectious diseases, announced two new milestones regarding its activities in China |
|
|
|
|
|
|
 |
|
 |
|
|
|
|
|
|
|
|
|
|
FEATURES |
|
|
|
|
Revolution in deriving blood protein
|
|
| Wuhan Healthgen has utilized the knowledge of expressing blood protein in an unconventional method and are conducting research and manufacturing services for expressing and producing proteins es utilizing the rice endosperm-specific expression |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PEOPLE |
|
|
|
|
|
|
Chinese scientists awarded 7th Szent-Gyorgyi Prize
|
|
| The National Foundation for Cancer Research announced that Dr Zhen-Yi Wang and Dr Zhu Chen have been awarded the 7th annual Szent-Gyorgyi Prize for Progress in Cancer Research for their innovative research in acute promyelocytic leukemia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EVENTS |
|
|
|
|
|
|
China calls for higher partnership in orthopedic diseases
|
|
| International President Forum advocated the establishment of an international cooperation platform to promote high-level medical services through education, research and best clinical practices during Chinese Orthopedic Association 2011 Congress |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
R & D |
|
|
|
|
|
|
Quintiles launches China CRO -Kun Tuo
|
|
| Quintiles, a fully integrated biopharmaceutical services company announced the launch of Kun Tuo (koon-TOO-ah), a local CRO built to service the unique needs of the Chinese biopharmaceutical industry |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POLICIES |
|
|
|
|
Amerigen, VIWA sign MoU to develop generic medicines for China
|
|
| Amerigen Pharmaceuticals and VIWA Pharmaceutical jointly announced the signing of a memorandum of understanding setting out their intention to establish a joint venture to develop and register a range of branded generic medicines for sale in China |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PRODUCTS |
|
|
|
|
|
|
Novartis gets approval for Lucentis
|
|
| Novartis received regulatory approval in China from the State Food and Drug Administration for Lucentis to treat wet age-related macular degeneration and is also launching Galvus |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TRENDS & ANALYSIS |
|
|
|
|
India, China boosting API: Companies & Markets
|
|
| According to London based analysis company, Companies & Markets, the Development in the High Potency Active Pharmaceutical Ingredient (HPAPI) and Biogeneric drugs is boosting the growth of the Active Pharmaceutical Ingredient (API) market. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
